In conclusion, the FGF7 family—except for FGF22 whose role in breast cancer has not been reported yet—plays a crucial role not only in the formation of mammary gland during development, but also in breast cancer initiation, progression and resistance to therapies. This evidence concerns the gene FGF22 and breast cancer.